SE8201768L - Nytt vaccin - Google Patents
Nytt vaccinInfo
- Publication number
- SE8201768L SE8201768L SE8201768A SE8201768A SE8201768L SE 8201768 L SE8201768 L SE 8201768L SE 8201768 A SE8201768 A SE 8201768A SE 8201768 A SE8201768 A SE 8201768A SE 8201768 L SE8201768 L SE 8201768L
- Authority
- SE
- Sweden
- Prior art keywords
- strain
- rabies virus
- vaccine
- virus
- under
- Prior art date
Links
- 241000711798 Rabies lyssavirus Species 0.000 claims abstract 3
- 230000000968 intestinal effect Effects 0.000 claims abstract 2
- 210000001161 mammalian embryo Anatomy 0.000 claims abstract 2
- 229960005486 vaccine Drugs 0.000 claims abstract 2
- 229940124861 Rabies virus vaccine Drugs 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 238000011109 contamination Methods 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000000120 cytopathologic effect Effects 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 241000700605 Viruses Species 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010037742 Rabies Diseases 0.000 abstract 1
- 210000004748 cultured cell Anatomy 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Claims (1)
1. Forfarande for framstdllning as levande eller inaktiverade rabiesvirusvaccin for parenteral eller icke-parenteral, t ex oral eller intestinal administrering, 66nnetec6n a t Stray, att de hLtrror fran stamen as rabiesvirus nov. spec. no 675, erhAllen enom propagering rev HEH Flury vaccin i primar eller sekundEr SPF honsembryofibroblaster, fOljt av isolering och rening av stamen, och deponerad i den tjeckoslovakiska nationella samlingen as typkulturer i Instituter, for Hygien Oct Epidemiologi Prag under numret INC IC AO 4/77, caret dens mutanter och varianter sore uppvisar den reproducerbart signifikanta cytopatiska effekten och ovriga specifika egenskaper hos stammen err 675, genom odling as cellkulturer in vitro och under tillampnine aV brukliga och fOreskrivna Atgarder `Or att eliminera bakteriell och/eller viral kontaminering.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3258/77A GB1596653A (en) | 1977-01-26 | 1977-01-26 | Vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8201768L true SE8201768L (sv) | 1982-03-19 |
| SE443924B SE443924B (sv) | 1986-03-17 |
Family
ID=9754946
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7800781A SE444453B (sv) | 1977-01-26 | 1978-01-23 | Sett att isolera en ny stam av rabiesvirus |
| SE8201768A SE443924B (sv) | 1977-01-26 | 1982-03-19 | Sett att framstella ett rabiesvaccin |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7800781A SE444453B (sv) | 1977-01-26 | 1978-01-23 | Sett att isolera en ny stam av rabiesvirus |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US4320115A (sv) |
| JP (2) | JPS5394084A (sv) |
| AT (1) | AT368005B (sv) |
| BE (1) | BE863368A (sv) |
| CA (1) | CA1112167A (sv) |
| CH (2) | CH659084A5 (sv) |
| DE (1) | DE2803240B2 (sv) |
| DK (1) | DK36378A (sv) |
| ES (2) | ES466359A1 (sv) |
| FI (1) | FI59812C (sv) |
| FR (1) | FR2378859B1 (sv) |
| GB (1) | GB1596653A (sv) |
| IE (1) | IE46498B1 (sv) |
| IT (1) | IT1192756B (sv) |
| LU (1) | LU78951A1 (sv) |
| NL (1) | NL174371C (sv) |
| NO (1) | NO780156L (sv) |
| PT (1) | PT67554B (sv) |
| SE (2) | SE444453B (sv) |
| ZA (1) | ZA78421B (sv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4347239A (en) | 1980-07-30 | 1982-08-31 | Norden Laboratories, Inc. | Inactivated rabies vaccine for veterinary use |
| US4429045A (en) | 1980-07-30 | 1984-01-31 | Norden Laboratories, Inc. | Rabies virus adapted for growth in swine testicle cell culture |
| EP0100752A3 (de) * | 1982-08-04 | 1985-04-17 | Veterinär-Bakteriologisches Institut der Universität Bern | Verfahren zur Herstellung eines neuen Tollwut-Impfstoffs, Behälter und Mittel zu dessen Verabreichung und Verfahren zur oralen Immunisierung |
| JPS6147187A (ja) * | 1984-08-10 | 1986-03-07 | Chemo Sero Therapeut Res Inst | 狂犬病ウイルスの精製方法 |
| DE3526809A1 (de) * | 1985-07-26 | 1987-04-02 | Behringwerke Ag | Tollwut-lebendimpfstoff |
| CA1249518A (en) * | 1985-09-06 | 1989-01-31 | Connaught Laboratories Limited | Oral immunization of mammals |
| US7094391B1 (en) * | 1988-10-24 | 2006-08-22 | The University Of Texas System | Compositions and methods for administering Borrelia burgdorferi antigens |
| AU2359195A (en) * | 1994-04-19 | 1995-11-10 | Thomas Jefferson University | Viral ribonucleocapsid as an immunological enhancer |
| US6495360B1 (en) * | 1999-05-28 | 2002-12-17 | Photogen, Inc. | Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins |
| US20030118628A1 (en) * | 2001-04-05 | 2003-06-26 | Tutuncu Nurhan Pinar | Confectionery product having a salivation region and an oral comfort region |
| RU2402348C1 (ru) * | 2009-05-13 | 2010-10-27 | Государственное научное учреждение Всероссийский научно-исследовательский и технологический институт биологической промышленности РАСХН | Вакцина антирабическая сухая для крупного и мелкого рогатого скота |
| CN112342185B (zh) * | 2020-11-11 | 2022-12-02 | 深圳市卫光生物制品股份有限公司 | 一种鸡胚细胞狂犬病病毒的生物反应器工艺 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1015262A (en) * | 1962-02-09 | 1965-12-31 | Nat Res Dev | Virus culture |
| US3255080A (en) * | 1962-08-06 | 1966-06-07 | Dow Chemical Co | Live rabies virus vaccine and method for the production thereof |
| US3397267A (en) * | 1964-09-21 | 1968-08-13 | Research Corp | Method of producing rabies vaccine |
| FR1567869A (sv) * | 1967-06-22 | 1969-05-23 | ||
| US4014991A (en) * | 1976-01-23 | 1977-03-29 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Oral rabies immunization of carnivores |
-
1977
- 1977-01-26 GB GB3258/77A patent/GB1596653A/en not_active Expired
-
1978
- 1978-01-16 NO NO780156A patent/NO780156L/no unknown
- 1978-01-20 NL NLAANVRAGE7800708,A patent/NL174371C/xx not_active IP Right Cessation
- 1978-01-20 FI FI780184A patent/FI59812C/fi not_active IP Right Cessation
- 1978-01-20 PT PT67554A patent/PT67554B/pt unknown
- 1978-01-23 SE SE7800781A patent/SE444453B/sv not_active IP Right Cessation
- 1978-01-24 ZA ZA00780421A patent/ZA78421B/xx unknown
- 1978-01-24 CA CA295,550A patent/CA1112167A/en not_active Expired
- 1978-01-24 IE IE161/78A patent/IE46498B1/en not_active IP Right Cessation
- 1978-01-25 AT AT0052678A patent/AT368005B/de not_active IP Right Cessation
- 1978-01-25 JP JP715078A patent/JPS5394084A/ja active Granted
- 1978-01-25 CH CH1456/86A patent/CH659084A5/de not_active IP Right Cessation
- 1978-01-25 DK DK36378A patent/DK36378A/da not_active Application Discontinuation
- 1978-01-25 US US05/872,056 patent/US4320115A/en not_active Expired - Lifetime
- 1978-01-25 DE DE2803240A patent/DE2803240B2/de not_active Withdrawn
- 1978-01-25 CH CH825/78A patent/CH658192A5/de not_active IP Right Cessation
- 1978-01-25 IT IT67143/78A patent/IT1192756B/it active
- 1978-01-26 LU LU78951A patent/LU78951A1/xx unknown
- 1978-01-26 FR FR7802215A patent/FR2378859B1/fr not_active Expired
- 1978-01-26 ES ES466359A patent/ES466359A1/es not_active Expired
- 1978-01-26 BE BE184675A patent/BE863368A/xx not_active IP Right Cessation
- 1978-05-17 ES ES469937A patent/ES469937A1/es not_active Expired
-
1981
- 1981-10-13 US US06/310,447 patent/US4400472A/en not_active Expired - Fee Related
-
1982
- 1982-03-19 SE SE8201768A patent/SE443924B/sv not_active IP Right Cessation
- 1982-10-15 JP JP57181202A patent/JPS5877822A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Okamoto et al. | Antigenic relationships of selected strains of infectious pancreatic necrosis virus and European eel virus | |
| Plummer et al. | COMPARATIVE STUDIES OF TYPE'AND TYPE &" herpes simplex" viruses | |
| SE8201768L (sv) | Nytt vaccin | |
| Clark | Rabies viruses increase in virulence when propagated in neuroblastoma cell culture | |
| DK0587873T3 (da) | Fremgangsmåde til opnåelse af celler, der er inficeret med en virus, der er forbundet med dissemineret sklerose | |
| Clark | Rabies serogroup viruses in neuroblastoma cells: propagation," autointerference," and apparently random back-mutation of attenuated viruses to the virulent state | |
| GB1522006A (en) | Feline calicivirus vaccine and a process for the production thereof | |
| JPS6216933B2 (sv) | ||
| ES373631A1 (es) | Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret. | |
| Bather et al. | Characteristics of the in vitro assay of murine sarcoma virus (Moloney) and virus-infected cells | |
| Takemoto et al. | Influence of acid polysaccharides on plaque formation by influenza A2 and B viruses | |
| Turner et al. | Potentiation of murine sarcoma virus (Harvey)(Moloney) oncogenicity in lactic dehydrogenase-elevating virus-infected mice | |
| Coetzee et al. | Transmission of jaagsiekte (ovine pulmonary adenomatosis) by means of a permanent epithelial cell line established from affected lungs | |
| Loebenstein | Native protein, an immunizing agent against virus infection | |
| Mathur et al. | Induction of suppressor cells in Japanese encephalitis virus infected mice | |
| EP0156478A3 (en) | Propagation of group ii avian adeno (aa) virus in avian cell culture and vaccine produced | |
| US4112068A (en) | Canine lung cell strain culture systems and processes for the cultivation of viruses and vaccines therefrom | |
| GB1274820A (en) | Highly attenuated newcastle disease virus vaccine and production thereof | |
| YU46029B (sh) | Postopek za pripravo živega cepiva proti mumpsu | |
| JPH0571226B2 (sv) | ||
| YAMAZI et al. | Characterization of temperature-sensitive mutants of measles virus: Temperature-shift experiment | |
| US3418210A (en) | Hamster ascites tumor cell line bhk 21/c.13/t.6/ascites useful in submerged serum-free agar cultures to support virus growth | |
| GB1015262A (en) | Virus culture | |
| Yura et al. | A latent infection of herpes simplex virus type 2 in a human neuroblastoma cell line IMR-32 | |
| BLACK | Characterization of temperature-sensitive mutants of measles virus: temperature-shift experiment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8201768-2 Effective date: 19940810 Format of ref document f/p: F |